Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
Controlled Substances Act
|
Restricts Rx refills
Track Rx, dispensing, purchase of listed substances Substances listed by abuse potential I-V |
|
Schedule I
|
High abuse potential, no med use approved
|
|
Schedule II
|
Written Rx ONLY, no refills (most opiods)
Locked in cabinets and "signed out" by LN; period counts to keep track of use; document and witness if wasted |
|
Schedule III/IV
|
Oral/written Rx, refill X5 w/in 6 mo.
Locked in cabinets and "signed out" by LN; period counts to keep track of use; document and witness if wasted |
|
Schedule V
|
dispensed w/o pharm Rx to adults w/ signature and address; may be limited by state law
|
|
Pharmodynamics
|
Study of biochemical/physiologic effects of drugs and their mechanisms of action = what the drug does to the body
|
|
Pharmokinetics
|
Absorption, distribution, biotransformation, and excretion of drugs combined w/ dosage determine concentration of drug at its site of action = intensity of its effects as a function of time
|
|
Pharmacotherapeutics
|
Use of drugs in the prevention and treatment of disease
|
|
ADME
|
Absportion, distribution, metabolism, excretion can explain variation among different persons' drug responses
|
|
Passive diffusion
|
Moves down concentration gradient until concentration is equal; most dominant method of drug transport
|
|
Facilitated diffusion (carrier-mediated; carriers are selective and saturable)
|
Carrier mediated by no E! required, important for endogenous substances that move at too slow of a rate
|
|
Active transport
|
Moves w/o regards to concentration gradient, needs E!
|
|
Factors affecting drug transport
|
Molecule size/shape
Solubulity Degree of ionization (nonionized = lipid soluble) Dissolution (pill/powder/liquid) Circulation to site Route of administration (IV - inhaled - IM/SQ - SL - oral = topical) |
|
First pass effect
|
PO absorbed in small intestine, blood circulates to liver to be metabolized and/or inactivation; therefore PO doses must be higher
|
|
Liposomes (topical)
|
Spherical shells of fats in aqueous medium that can enhance per cutaneous absorption and penetrate epidermal barriers more efficiently
|
|
Microgels (topical)
|
Polymers that can enhance solubilization of certain drugs and enhancing penetration w/ less irritant
|
|
Transfersomes (topical)
|
Highly deformable, ultraflexible lipid vesicles that penetrate the skin when applied nonocclusively; pressure waves from laser radiation can permeabilize the stratum corneum for a system for transdermal drug delivery
|
|
T/F: other drugs and food do not affect certain drugs
|
F: TCN binds w/ calcium to form insoluble form; can affect bioavailability (amt of active drug in system)
|
|
Target tissue
|
Tissue the drug is supposed to affect
|
|
Factors affecting distribution
|
CO and regional blood flow
Drug storage in body tissues (drug has greater affinity to certain tissues) |
|
Compartments (drug storage sites)
|
Plasma proteins (albumin)
Neutral body fat Bone (mainly metals) |
|
Redistribution
|
Happens when plasma concentrations drop and storage sites release to maintain concentration gradient (gamma)
|
|
Blood-brain barrier
|
Most drugs DO NOT cross but lipid-soluble pass more readily
Drugs may be formulated to be absorbed or not in CSF In meningitis BBB isn't very effective |
|
Placenta
|
POOR barrier
40 minutes for drug serum level in mom and baby to equalize (fetus has poor liver metabolism and fetus is small = greater relative concentrations of drug in fetus) |
|
T/F: Drugs are made less lipid soluble
|
T: more soluble in body fluids and therefore more likely to be excreted
|
|
T/F: All drugs begin as active forms than be come inactive
|
F: some drugs are inactive to active and must be absorbed to do so
|
|
T/F: All drugs are broken down and excreted
|
F: some drugs are excreted unchanged d/t lack of enzymes, hypersensitive people who don't metabolize as fast
|
|
Which organ is primary organ of metabolism?
|
Liver; the hepatic microsomal enzymes (nonspecific)
|
|
Factors affecting metabolism
|
Age (infants don't develop until 1-2, most active until teens, elderly are slower)
Genetics (fast acetylators vs slow; 50% of Caucasians are slow, 2% of NA are slow) Disease states (especially hepatic) Other drugs |
|
Induced hepatic enzymes:
|
Sped up metabolism
|
|
Inhibited hepatic enzymes:
|
Slowed metabolism
|
|
Which organ is the major excretion source?
|
Kidney (some in GI, mammary glands, sweat glands, resp tract); designed to excrete H2O soluble substances b/c it is 25X more permeable than other membranes
|
|
Tubular reabsorption
|
can manipulate by manipulating urine pH or pH of drug to increase excretion
|
|
Entero-hepatic recycling
|
Drug is absorbed into bloodstream - through liver - excreted in bile - reabsorbed from GI - into blood
Neo-ionized/lipid soluble are more readily recycled |
|
Factors modifying excretion
|
Urine pH
Age Drug interactions Renal disease |